Blogs
News
-
Collaborations | 02 Dec, 2025
Porton Advanced’s End-to-End CDMO Service Drives Qihan Biotech’s First-in-Class Dual-targeting CAR-T IND Approval in China
-
Collaborations | 30 Sep, 2025
Porton Advanced and RongCan Biotech Announce Strategic Collaboration to Advance LNP Delivery Technology for Nucleic Acid and Cell Therapies












